Beranda › Infeksi Pneumokokus › California
Uji klinis Infeksi Pneumokokus di California
5 studi untuk Infeksi Pneumokokus mencari peserta di lokasi di California.
Teks studi resmi (Bahasa Inggris)
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
- Madera Family Medical Group ( Site 1004), Madera
Menerima pesertaFase 1Sukarelawan sehat diterima
2 Months – 15 Months · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07300267A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
- Orange County Research Center, Lake Forest
- Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 18 hingga 49 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07794748A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
- Advanced Research Center, Inc., Anaheim
- San Gabriel Woman's Health, Arcadia
- Coast Clinical Research, LLC, Bellflower
- dan 5 lainnya
Menerima pesertaFase 3Sukarelawan sehat diterima
42 Days – 211 Days · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07629440Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
- Apex Research Group, Fair Oaks
- Orange County Research Institute, Ontario
Menerima pesertaFase 3Sukarelawan sehat diterima
15 Months – 17 Years · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07660198Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
- Matrix Clinical Research - Huntington Park- Site Number : 8400029, Huntington Park
- Community Clinical Research- Site Number : 8400030, Los Angeles
- Matrix Clinical Research - Los Angeles- Site Number : 8400028, Los Angeles
Menerima pesertaFase 3Sukarelawan sehat diterima
42 Days – 89 Days · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT07348692Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.